Neonatal drug utilisation
Conditions
Interventions
Observation group:None
Sponsors
The University of Hongkong - Shenzhen Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients discharged from the NICU or paediatric cardiac intensive care unit between 1 July 2022 and 30 June 2023 who had been discharged from the NICU or paediatric cardiac intensive care unit.
Exclusion criteria
Exclusion criteria: Children >28 days of age at admission were excluded; Neonates who received observation only, < 1 drug were excluded; Neonates with missing data on birth weight, sex, or gestational age were excluded; Neonates 24 hours < of admission were excluded. Neonates treated with the following drugs alone and no other drugs were excluded: vitamin K prophylaxis; prophylactic ophthalmic therapy; Vaccine; Intravenous fluids (including 0.9% sodium chloride, 5%/10%/50% glucose injection, and sterile solution for injection), parenteral nutrition, heparin for intravenous access, oxygen, and electrolytes (such as calcium gluconate, magnesium sulfate, and potassium chloride).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of drug types used,;Drug dosage;Percentage of use of high-alert drugs;Percentage of off-label medications; | — |
Countries
China
Contacts
Public ContactZhuo Yubo
The University of Hongkong - Shenzhen Hospital
Outcome results
None listed